Ajanta Pharma Ltd shares file as trustee Aayush Agrawal files disclosure under SEBI takeover regulations
Why did Ajanta Pharma Ltd shares jump today?
Ajanta Pharma Ltd shares traded higher on Friday, rising 0.4% to a current price of ₹3,555.0. This positive movement was recorded at 01:46 PM in the session, reflecting investor interest following a regulatory disclosure filed with the stock exchanges.
The exchange received a disclosure under SEBI's Substantial Acquisition of Shares and Takeovers Regulations. The filing pertains to Aayush Agrawal, acting as a trustee of the Aayush Agrawal Trust. The details involve the release and creation of a pledge on shares. Specifically, it mentions Gabs Investments Pvt Ltd, which holds 10.07% of the company's total share capital. The event noted is the release and creation of encumbrance on 27,70,000 shares, representing 2.22% of the company's equity.
Such disclosures are routine and inform the market about changes in the pledged holdings of promoters or related entities. While the filing itself is a compliance requirement, the positive share price reaction suggests the market interpreted the news, potentially the release of the pledge, as a favorable development for the company's promoter group stability.
What does Ajanta Pharma Ltd do?
Ajanta Pharma Limited is identified as a target company whose shares are listed on the BSE and NSE stock exchanges. The information pertains to a regulatory disclosure concerning the release and creation of a pledge on shares held by the promoter, Aayush Agrawal, in his capacity as a trustee.
The document outlines a specific event involving the release and creation of an encumbrance, detailing the promoter's holdings and the post-event status of the encumbered shares. It provides a structured format for reporting such transactions in compliance with takeover regulations.
Ajanta Pharma Ltd Financials
In CroresAjanta Pharma Ltd demonstrated strong financial growth in the first half of 2026. The company's quarterly revenue increased from ₹1421.64 crores in March 2026 to ₹1625.96 crores in June 2026, representing a significant quarter-over-quarter expansion. Concurrently, net profit followed a similar upward trajectory, rising from ₹266.7 crores to ₹334.22 crores in the same period, indicating robust bottom-line growth alongside the top-line expansion.
Ajanta Pharma Ltd Shareholding Pattern
Promoter holding stands at 63.49% of the total share capital. Foreign Institutional Investors (FIIs) hold 7.68% stake in the company, while Domestic Institutional Investors (DIIs) hold 21.8%. Public shareholders hold the remaining 7.03% stake in Ajanta Pharma Ltd.
Ajanta Pharma Ltd FAQs
Q: Why did Ajanta shares jump 0.4% today?
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 27, 2026 for Aayush Agrawal, trustee ..... This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Ajanta Pharma Ltd?
As per the latest data, promoters hold 63.49% stake in Ajanta Pharma Ltd, while FII holding stands at 7.68%. Domestic institutional investors hold 21.8%, and public shareholders account for 7.03% of the equity.
Q: What is the current stock price of Ajanta Pharma Ltd?
Ajanta Pharma Ltd shares are currently trading at ₹3555.0, recording a gain of 0.4% from the previous close.
Q: What is the market capitalization of Ajanta Pharma Ltd?
The company currently has a market capitalization of ₹44414.61 crore, reflecting its valuation in the Indian equity market.